The data is from a single patient sample, and the assay conditions have not been optimised. How does ASX allow them to announce this???
Ann: BARD1 Demonstrates Feasibility of SubB2M-Based IHC Test, page-18
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.18M | |||
| Open | High | Low | Value | Volume |
| 45.0¢ | 45.0¢ | 45.0¢ | $6.16K | 13.68K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 42909 | 45.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.0¢ | 6850 | 1 |
View Market Depth
| Last trade - 13.26pm 11/11/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |